US 9687448
Nucleic acid lipid particle formulations
granted A61KA61K31/713A61K9/0019
Quick answer
US patent 9687448 (Nucleic acid lipid particle formulations) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/713, A61K9/0019, A61K9/1272, A61K9/1617